EN PL

EMEA: Announcement of European Medicines Agency priorities for adverse drug reaction research

07.08.2009
At its plenary meeting on 19 March 2009, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted its 2010 priorities for drug safety research based on recommendations from the CHMP’s Pharmacovigilance Working Party.